Periodic reports (PL)
Announcement date: 15/11/2022 17:10

[ENG] ESPI REPORT Q3 2022 – QUARTERLY REPORT FOR THE Q3 2022 – TRANSLATION

QUARTERLY REPORT OF PURE BIOLOGICS S.A. FOR THE Q3 2022

 

SELECTED FINANCIAL DATA PLN thousand PLN thousand EUR thousand EUR thousand
01.01.2022-30.09.2022 01.01.2021-30.09.2021 01.01.2022-30.09.2022 01.01.2021-30.09.2021
I. Operating revenues 9 702 10 237 2 030 2 184
II. Total operating costs 27 088 20 923 5 668 4 463
III. Operating profit (loss) (17 327) (10 684) (3 626) (2 279)
IV. Profit  (loss) before tax (18 443) (11 072) (3 859) (2 362)
V. Net profit (loss) (18 443) (11 072) (3 859) (2 362)
VI. Net cash flows from operating activities (12 290) (18 479) (2 572) (3 942)
VII. Net cash flows from investment activities 23 303 (586) 4 876 (125)
VIII. Net cash flows from financial activities (1 517) 49 303 (317) 10 517
IX. Total net cash flows 9 496 30 237 1 987 6 450
As at 30.09.2022 As at 31.12.2021 As at 30.09.2022 As at 31.12.2021
X. Total assets/liabilities 30 260 47 190 6 214 10 260
XI. Tangible assets 5 400 4 175 1 109 908
XII. Current assets 24 860 43 015 5 105 9 352
XIII. Equity capital 24 344 39 486 4 999 8 585
XIV. Liabilities and provisions for liabilities 5 916 7 704 1 215 1 675
XV. Long-term liabilities 1 822 2 155 374 468
XVI. Short-term liabilities 4 094 5 549 841 1 206
XVII. Weighted average number of ordinary shares 2 254 000 2 210 044 2 254 000 2 210 044
XVIII. Profit (loss) per ordinary share (in PLN/EUR) (8,18) (5,01) (1,71) (1,07)
XIX. Number of shares at the end of the period 2 254 000 2 254 000 2 254 000 2 254 000
XX. Book value per share (in PLN/EUR) 10,80 17,87 2,22 3,88
 

 

The selected financial figures presented in the report have been converted into euro as follows:
1] Items relating to the statement of profit or loss and other total income, the cash flow statement and the statement of changes in equity were converted at an exchange rate representing the arithmetic average of the exchange rates published by the National Bank of Poland:
– for period between 01.01.2022 and 30.09.2022: PLN 4,7787
– for period between 01.01.2021 and 30.09.2021: PLN 4,6880
2] The balance sheet items were converted according to the average exchange rate announced by the National Bank of Poland, in force on the balance sheet date; this exchange rate amounted to:
– As at 30.09.2022: PLN 4,8698
– As at 31.12.2021: PLN 4,5994

 

REPORT CONTENT TRANSLATION

Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers